264 related articles for article (PubMed ID: 36430419)
1. Mitochondrial Fatty Acid β-Oxidation Disorders: From Disease to Lipidomic Studies-A Critical Review.
Guerra IMS; Ferreira HB; Melo T; Rocha H; Moreira S; Diogo L; Domingues MR; Moreira ASP
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430419
[TBL] [Abstract][Full Text] [Related]
2. Tracer-based lipidomics enables the discovery of disease-specific candidate biomarkers in mitochondrial β-oxidation disorders.
Schwantje M; Mosegaard S; Knottnerus SJG; van Klinken JB; Wanders RJ; van Lenthe H; Hermans J; IJlst L; Denis SW; Jaspers YRJ; Fuchs SA; Houtkooper RH; Ferdinandusse S; Vaz FM
FASEB J; 2024 Feb; 38(4):e23478. PubMed ID: 38372965
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
4. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
[TBL] [Abstract][Full Text] [Related]
5. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
Yamada K; Taketani T
J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H
J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472
[TBL] [Abstract][Full Text] [Related]
7. Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population.
Wang S; Leng J; Diao C; Wang Y; Zheng R
J Pediatr Endocrinol Metab; 2020 May; 33(6):683-690. PubMed ID: 32447334
[TBL] [Abstract][Full Text] [Related]
8. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
9. Blood cytokine patterns suggest a modest inflammation phenotype in subjects with long-chain fatty acid oxidation disorders.
McCoin CS; Gillingham MB; Knotts TA; Vockley J; Ono-Moore KD; Blackburn ML; Norman JE; Adams SH
Physiol Rep; 2019 Mar; 7(6):e14037. PubMed ID: 30912279
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience.
Maguolo A; Rodella G; Dianin A; Nurti R; Monge I; Rigotti E; Cantalupo G; Salviati L; Tucci S; Pellegrini F; Molinaro G; Lupi F; Tonin P; Pasini A; Campostrini N; Ion Popa F; Teofoli F; Vincenzi M; Camilot M; Piacentini G; Bordugo A
Mol Genet Metab Rep; 2020 Sep; 24():100632. PubMed ID: 32793418
[TBL] [Abstract][Full Text] [Related]
11. Muscle MRI in patients with long-chain fatty acid oxidation disorders.
Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G
J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961
[TBL] [Abstract][Full Text] [Related]
12. Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.
Alatibi KI; Hagenbuchner J; Wehbe Z; Karall D; Ausserlechner MJ; Vockley J; Spiekerkoetter U; Grünert SC; Tucci S
Cells; 2021 May; 10(5):. PubMed ID: 34069977
[TBL] [Abstract][Full Text] [Related]
13. Evidence that Oxidative Disbalance and Mitochondrial Dysfunction are Involved in the Pathophysiology of Fatty Acid Oxidation Disorders.
Ribas GS; Vargas CR
Cell Mol Neurobiol; 2022 Apr; 42(3):521-532. PubMed ID: 32876899
[TBL] [Abstract][Full Text] [Related]
14. Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid β-oxidation disorders in adult patients with rhabdomyolysis.
Al-Thihli K; Sinclair G; Sirrs S; Mezei M; Nelson J; Vallance H
J Inherit Metab Dis; 2014 Mar; 37(2):207-13. PubMed ID: 23296367
[TBL] [Abstract][Full Text] [Related]
15. Lipidomic and Proteomic Alterations Induced by Even and Odd Medium-Chain Fatty Acids on Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.
Alatibi KI; Tholen S; Wehbe Z; Hagenbuchner J; Karall D; Ausserlechner MJ; Schilling O; Grünert SC; Vockley J; Tucci S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638902
[TBL] [Abstract][Full Text] [Related]
16. Long-chain fatty acid oxidation disorders and current management strategies.
Vockley J
Am J Manag Care; 2020 Aug; 26(7 Suppl):S147-S154. PubMed ID: 32840329
[TBL] [Abstract][Full Text] [Related]
17. Oxidative damage in mitochondrial fatty acids oxidation disorders patients and the in vitro effect of l-carnitine on DNA damage induced by the accumulated metabolites.
de Moraes MS; Guerreiro G; Sitta A; de Moura Coelho D; Manfredini V; Wajner M; Vargas CR
Arch Biochem Biophys; 2020 Jan; 679():108206. PubMed ID: 31760122
[TBL] [Abstract][Full Text] [Related]
18. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E
Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311
[TBL] [Abstract][Full Text] [Related]
19. Higher dietary protein intake preserves lean body mass, lowers liver lipid deposition, and maintains metabolic control in participants with long-chain fatty acid oxidation disorders.
Gillingham MB; Elizondo G; Behrend A; Matern D; Schoeller DA; Harding CO; Purnell JQ
J Inherit Metab Dis; 2019 Sep; 42(5):857-869. PubMed ID: 31295363
[TBL] [Abstract][Full Text] [Related]
20. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.
Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M
Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
